IPO一周要闻丨香港上市井喷 北芯生命上会

Core Viewpoint - The recent week saw a quiet IPO market in Hong Kong, with three companies submitting applications and one company halting its IPO due to ongoing disputes, while several A-share companies announced preparations for Hong Kong IPOs [1][2]. A-Share Dynamics - Shenzhen Beixin Life Technology Co., Ltd. successfully passed its IPO review on July 18, aiming to raise 0.952 billion yuan, marking it as the second company this month to adopt the fifth set of standards for the Sci-Tech Innovation Board [2]. - Beixin Life focuses on innovative medical devices for cardiovascular disease diagnosis and treatment, and is recognized as a national high-tech enterprise [2]. Newly Listed Companies 1. Viliant Biotech-B (09887.HK) - Listed on July 17, raising approximately 1.01 billion HKD, becoming the first "B" labeled new stock in the Hong Kong innovative drug sector [3]. - The company has completed eight rounds of financing, totaling 1.084 billion yuan, and focuses on developing new therapies for cancer and autoimmune diseases [3]. 2. Lianqi Technology (06610.HK) - Listed on July 16, raising about 5.89 billion HKD, with projected revenue of 3.64 billion yuan and net profit of 1.34 billion yuan for 2024 [4][5]. - The company specializes in high-performance, low-power interconnect solutions for cloud computing and AI infrastructure [4]. 3. Xingyuan Material (01908.HK) - Listed on July 15, raising approximately 3.31 billion HKD, and is the leading manufacturer of lithium-ion battery separators globally [6]. - The company has seen its market share grow from 11.0% in 2020 to 14.4% in 2024, with significant clients including LG Energy, Samsung SDI, and CATL [6]. 4. Lao Xiang Ji (09981.HK) - Listed on July 15, raising about 1.55 billion HKD, and is the largest Chinese fast-food brand by transaction volume in 2024 [7][8]. - The company operates a mix of direct and franchise models, with a total of 1,564 stores across nine provinces and 58 cities as of April 30, 2025 [7][8]. Companies Submitting Applications 1. WeDoctor Holdings - Submitted its application on July 16, with Morgan Stanley as the exclusive sponsor, ranking second in China's online medical service market by revenue [9]. - The company aims to enhance grassroots medical institutions' capabilities through AI applications [9][10]. 2. Hive Energy - Submitted its application on July 15, with CITIC International and Citigroup as joint sponsors, ranking sixth globally and third domestically in battery installation volume for 2024 [11][12]. Market Dynamics - The Shanghai Stock Exchange announced the termination of an IPO application by Wendoli Sunshade Materials [13]. - As of July 18, 2025, there are 34 companies that have passed the IPO review but have not yet received approval from the China Securities Regulatory Commission [13].